Oxford Nanopore Technologies founded in 2005 and a spin out from Oxford University is a specialist in developing DNA sequencing technologies.
Oxford Nanopore floated on the LSE on 29th September and surged more than 45% as the gene sequencing specialist made one of London’s best market debuts.
Within an hour of trading the stock had soared to 619.9p raising its market cap close to $5 billion.
Oxford Nanopore is a private company with its head quarters in the Oxford Science Park outside Oxford, UK, with satellite offices in Cambridge (UK), New York, Cambridge, San Francisco (US), Singapore, Shanghai, Beijing, and a broader commercial presence that includes Japan, Germany, France and India.
The company sells to more than 100 countries and is in a period of rapid growth.
How to buy Oxford Nanopore Technologies shares
You will need a trading account to invest.
- Select a share platform – See below our top platform picks
- Open your share account – To do this you will need your bank details and national insurance number
- Fund your account – You will need to fund your a/c with a debit or credit card or bank transfer
- Search for Oxford Nanopore using the stock code – Type in the stock code ONT into the search box
- Check out the latest info and price for the selected share – Some platforms offer free research and analysis
- Buy the share – Nice and easy!
Selected Platform:
Buy & Sell Oxford Nanopore Technologies
Capital is at risk.
- Buy & sell Oxford Nanopore Tech shares from £5.95
- No charge if you trade only shares
- No 1 investment platform in UK for private investors
UK Share Trading Apps 2023
| Trading Platforms: | Features:* | Go To Site: |
 | DEGIRO are one of largest and cheapest brokers in Europe. Access to over 50 markets in 30 countries. Low commissions/fees. User-friendly, simple platform. Investing involves risk of loss. | See Deal » |
 | AJ Bell offers overseas trading in 24 international markets. Capital at risk. | See Deal » |
 | Interactive Investor are the UK's #1 flat fee platform. Over 350,000 customers. Capital at risk. | See Deal » |
 | SAXO Access over 30,000+ stocks across 60+ exchanges worldwide. Ultra competitive pricing. Benefit from extensive charting with 50+ technical indicators, integrated Trade Signals and innovative risk management tools. Investing involves risk of loss. | See Deal » |
 | Hargreaves Lansdown The UK's #1 broker. Price improvement service helps you get the best price for your shares. Capital at risk. | See Deal » |
 | IG Trade & invest with the world's leading online trading provider.** Trade over 17,000 markets with spread bets and CFDs and invest in thousands of global shares & ETFs. Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money. Capital at risk. | See Deal » |
*Please note that additional fees may be applied by platform/App providers for their services.
** No 1 For CFDs and spread betting, based on revenue excluding FX (published financial statements, October 2021).
Financial performance of Oxford Nanopore Technologies before the IPO
Oxford Nanopore Technologies was valued at $3.2 billion in March 2021. The investment firm IP Group, which owns 15% of Oxford Nanopore Technologies, estimated its assets to be worth more than $470 million.
Other investors in the company include Amgen, the sovereign wealth fund GIC, and China Construction Bank International.
According to company representatives, going public will allow the company to attract international capital while also realizing its active growth and production expansion ambitions.
Prospects of Oxford Nanopore Technologies
Since the beginning of the COVID-19 pandemic, scientists in more than 85 countries have used the company’s technologies to track new mutations in the coronavirus.
The company’s MinIO device, which costs only $1,000, enables specialists to work without the assistance of large laboratories.
Oxford Nanopore Technologies also created a COVID-19 test that produces results in under an hour.
According to Grand View Research, the DNA sequencing market was valued at $ 4.7 billion in 2019 and is expected to grow to $ 11.2 billion by 2027.
The ongoing active phase of the pandemic, which, even with optimistic projections, is unlikely to end before 2022, is another factor influencing demand for the company’s services.
As a result, there is every reason to believe that Oxford Nanopore Technologies will continue to expand aggressively.
Based in Oxford the company has 600 staff with offices in Cambridge, New York, San Francisco, Singapore & Beijing.
IMPORTANT:
No news, feature article or comment should be seen as a personal recommendation to invest. Prior to making any decision to invest, you should ensure that you are familiar with the risks associated with a particular plan. If you are at all unsure of the suitability of a particular product, both in respect of its objectives and its risk profile, you should seek independent financial advice.
The value of shares, ETFs and ETCs bought through a share dealing account, a stocks and shares ISA or a SIPP can fall as well as rise, which could mean getting back less than you originally put in. Past performance is no guarantee of future results.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 67%-70% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money. Professional clients can lose more than they deposit. All trading involves risk.